ActiQs / Forskning

PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för beta-lapachone. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

16 träffar

Bibliografisk träff 2015-01-01

Beta-Lapachone Suppresses Non-small Cell Lung Cancer Proliferation through the Regulation of Specificity Protein 1.

Jeon YJ, Bang W, Choi YH, Shim JH, Chae JI.

Biol Pharm Bull · research support, non-u.s. gov't; journal article · DOI 10.1248/bpb.b15-00159

Bibliografisk träff 2014-10-29

Mechanistic studies of cancer cell mitochondria- and NQO1-mediated redox activation of beta-lapachone, a potentially novel anticancer agent.

Li JZ, Ke Y, Misra HP, Trush MA, Li YR, Zhu H, Jia Z.

Toxicol Appl Pharmacol · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.taap.2014.10.012

Bibliografisk träff 2013-06-30

Enhancement of radiation effect using beta-lapachone and underlying mechanism.

Ahn KJ, Lee HS, Bai SK, Song CW.

Radiat Oncol J · review-article; journal article · DOI 10.3857/roj.2013.31.2.57

Bibliografisk träff 2012-10-11

Beta-lapachone, a modulator of NAD metabolism, prevents health declines in aged mice.

Lee JS, Park AH, Lee SH, Lee SH, Kim JH, Yang SJ, Yeom YI, Kwak TH, Lee D, Lee SJ, Lee CH, Kim JM, Kim D.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0047122

Bibliografisk träff 2012-09-23

β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.

Xu J, Wagoner G, Douglas JC, Drew PD.

J Neuroimmunol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.jneuroim.2012.09.004

Bibliografisk träff 2012-06-26

Anticancer efficacy and subcellular site of action investigated by real-time monitoring of cellular responses to localized drug delivery in single cells.

Zheng XT, Chen P, Li CM.

Small · research support, non-u.s. gov't; journal article · DOI 10.1002/smll.201102636

Bibliografisk träff 2012-04-19

β-Lapachone analogs with enhanced antiproliferative activity.

Ríos-Luci C, Bonifazi EL, León LG, Montero JC, Burton G, Pandiella A, Misico RI, Padrón JM, Padrón JM.

Eur J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ejmech.2012.04.008

Bibliografisk träff 2009-01-01

In vitro metabolism of beta-lapachone (ARQ 501) in mammalian hepatocytes and cultured human cells.

Miao XS, Zhong C, Wang Y, Savage RE, Yang RY, Kizer D, Volckova E, Ashwell MA, Chan TC.

Rapid Commun Mass Spectrom · journal article · DOI 10.1002/rcm.3835

Bibliografisk träff 2008-07-31

Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of ARQ 501 (beta-lapachone) in plasma and tumors from nu/nu mouse xenografts.

Savage RE, Hall T, Bresciano K, Bailey J, Starace M, Chan TC.

J Chromatogr B Analyt Technol Biomed Life Sci · validation study; journal article · DOI 10.1016/j.jchromb.2008.07.031

Bibliografisk träff 2008-04-01

Synthetic methods for the preparation of ARQ 501 (beta-Lapachone) human blood metabolites.

Yang RY, Kizer D, Wu H, Volckova E, Miao XS, Ali SM, Tandon M, Savage RE, Chan TC, Ashwell MA.

Bioorg Med Chem · journal article · DOI 10.1016/j.bmc.2008.03.073

Bibliografisk träff 2008-01-28

Identification of a novel glucosylsulfate conjugate as a metabolite of 3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione (ARQ 501, beta-lapachone) in mammals.

Savage RE, Tyler AN, Miao XS, Chan TC.

Drug Metab Dispos · comparative study; journal article · DOI 10.1124/dmd.107.018655

Bibliografisk träff 2008-01-07

Identification of the in vitro metabolites of 3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione (ARQ 501; beta-lapachone) in whole blood.

Miao XS, Song P, Savage RE, Zhong C, Yang RY, Kizer D, Wu H, Volckova E, Ashwell MA, Supko JG, He X, Chan TC.

Drug Metab Dispos · comparative study; journal article · DOI 10.1124/dmd.107.018572

Bibliografisk träff 2006-07-14

Beta-lapachone.

Cunha-Filho MS, Landin M, Martinez-Pacheco R, Dacunha-Marinho B.

Acta Crystallogr C · research support, non-u.s. gov't; journal article · DOI 10.1107/s0108270106021706

Bibliografisk träff 2006-01-01

Beta-lapachone, a quinone isolated from Tabebuia avellanedae, induces apoptosis in HepG2 hepatoma cell line through induction of Bax and activation of caspase.

Woo HJ, Park KY, Rhu CH, Lee WH, Choi BT, Kim GY, Park YM, Choi YH.

J Med Food · research support, non-u.s. gov't; journal article · DOI 10.1089/jmf.2006.9.161

Bibliografisk träff 1987-10-01

Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.

Boothman DA, Greer S, Pardee AB.

Cancer Res · research support, u.s. gov't, p.h.s.; journal article

Bibliografisk träff 1984-02-01

Beta-lapachone greatly enhances MMS lethality to human fibroblasts.

Boorstein RJ, Pardee AB.

Biochem Biophys Res Commun · research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/0006-291x(84)91469-4